Neuberger Berman Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Neuberger Berman Group’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,495	Closed	-$217K	–	1906
2022 Q1	$217K	Hold	3,495	–	–	﹤0.01%	1782
2021 Q4	$249K	Sell	3,495 -40	-1%	-$2.9K	﹤0.01%	1772
2021 Q3	$265K	Sell	3,535 -415	-11%	-$31.6K	﹤0.01%	1637
2021 Q2	$305K	Hold	3,950	–	–	﹤0.01%	1607
2021 Q1	$292K	Hold	3,950	–	–	﹤0.01%	1616
2020 Q4	$277K	Sell	3,950 -50	-1%	-$3.17K	﹤0.01%	1535
2020 Q3	$226K	Hold	4,000	–	–	﹤0.01%	1524
2020 Q2	$233K	Buy	+4,000	New	+$218K	﹤0.01%	1457
2020 Q1	–	Sell	-4,000	Closed	-$223K	–	1601
2019 Q4	$223K	Buy	+4,000	New	+$209K	﹤0.01%	1453
2019 Q3	–	Sell	-4,000	Closed	-$214K	–	1583
2019 Q2	$214K	Hold	4,000	–	–	﹤0.01%	1484
2019 Q1	$221K	Buy	+4,000	New	+$211K	﹤0.01%	1449
2018 Q4	–	Sell	-4,000	Closed	-$238K	–	1630
2018 Q3	$238K	Hold	4,000	–	–	﹤0.01%	1513
2018 Q2	$219K	Buy	+4,000	New	+$203K	﹤0.01%	1626
2017 Q1	–	Sell	-5,950	Closed	-$231K	–	1626
2016 Q4	$231K	Hold	5,950	–	–	﹤0.01%	1488
2016 Q3	$250K	Hold	5,950	–	–	﹤0.01%	1446
2016 Q2	$220K	Hold	5,950	–	–	﹤0.01%	1442
2016 Q1	$228K	Hold	5,950	–	–	﹤0.01%	1408
2015 Q4	$301K	Sell	5,950 -1,625	-21%	-$80.3K	﹤0.01%	1377
2015 Q3	$346K	Hold	7,575	–	–	﹤0.01%	1359
2015 Q2	$442K	Hold	7,575	–	–	﹤0.01%	1348
2015 Q1	$418K	Hold	7,575	–	–	﹤0.01%	1373
2014 Q4	$380K	Hold	7,575	–	–	﹤0.01%	1400
2014 Q3	$350K	Sell	7,575 -750	-9%	-$33.8K	﹤0.01%	1427
2014 Q2	$364K	Buy	+8,325	New	+$337K	﹤0.01%	1451

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AWA

Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $938M AUM 29.36% 1-Year Est. Return

Neuberger Berman Group's PBE Position: Q2 2022 in Review

Neuberger Berman Group sold out of Invesco Biotechnology & Genome ETF (PBE) in Q2 2022, closing a stake of 3,495 shares — an estimated $217K sold.

Neuberger Berman Group first reported a position in PBE in Q2 2014 and held it in 24 quarters. The position peaked at $442K in Q2 2015. 89 funds tracked by Wall St. Rank hold PBE as of Q2 2022.

Neuberger Berman Group reported no remaining Invesco Biotechnology & Genome ETF position as of Q2 2022 after selling out during the quarter.
Neuberger Berman Group sold 3,495 Invesco Biotechnology & Genome ETF shares in Q2 2022, an estimated $217K.
Neuberger Berman Group first reported a position in Invesco Biotechnology & Genome ETF in Q2 2014 and held it in 24 quarters.
Neuberger Berman Group's Invesco Biotechnology & Genome ETF position peaked at $442K in Q2 2015.
89 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2022.

Based on Neuberger Berman Group's 13F filing for Q2 2022, filed 15 Aug 2022.